Australia’s medtech, research and pharmaceutical sectors rely on highly specialised expertise. Clinical researchers, scientists, engineers, regulatory specialists and technical leaders are often sourced globally, not locally.
In these fields, immigration is rarely about filling high volumes of roles. It is about securing the right people, protecting intellectual capability and enabling research, trials and innovation to continue without disruption.
At Roam Migration Law, we help organisations in medtech, research and pharma use immigration law to support innovation, collaboration and long-term growth.
Why skilled migration is critical in medtech, research and pharma
Work in this sector is specialised, regulated and time sensitive. Delays in onboarding key personnel can stall research programs, clinical trials or product development.
We regularly support organisations facing:
- Difficulty sourcing niche scientific or technical expertise in Australia
- Global mobility needs for researchers and senior specialists
- Overseas experts required for trials, development or commercialisation
- Long-term retention challenges for high-value talent
Immigration strategy in this sector needs to align with funding cycles, research timelines and commercial priorities.
How visas are commonly used in this sector
Medtech, research and pharma employers often use a combination of temporary and permanent visas depending on the nature of the work.
Temporary visas are frequently used to bring in specialists for defined projects, research collaborations or early-stage development. Where the role becomes ongoing, a clear pathway to permanent residence is essential to retain critical knowledge and capability.
Permanent visas are commonly used for senior researchers, technical leaders and specialists who are central to long-term programs or product pipelines.
For organisations operating across borders, immigration planning often forms part of a broader global mobility strategy.
Common visa options for Medtech, Research & Pharma
Visa subclass | What it’s typically used for | Who it suits |
Subclass 482 – Skills in Demand (SID) | Sponsoring specialised scientific and technical roles | Medtech, research and pharma employers needing niche expertise |
Subclass 186 – Employer Nomination Scheme (ENS) | Permanent residence for critical long-term roles | Organisations retaining senior researchers or specialists |
Subclass 408 – Temporary Activity | Research, collaboration or project-based activities | Short-term or defined research engagements |
Subclass 400 – Temporary Work (Short Stay Specialist) | Highly specialised, non-ongoing work | Experts required for short-term technical input |
Subclass 189 – Skilled Independent | Permanent residence without employer sponsorship | Highly skilled professionals with strong credentials |
Subclass 190 – Skilled Nominated | Permanent residence with state or territory nomination | Specialists aligned with state innovation priorities |
Risks organisations often overlook
Immigration issues in this sector are often subtle but high impact.
Common risks include:
- Using short-term visas where roles become ongoing
- Losing key personnel due to lack of permanent pathways
- Delays caused by misaligned visa strategy and project timelines
- Underestimating the compliance obligations tied to sponsorship
For research-driven organisations, the loss of a single individual can disrupt entire programs.
How Roam Migration Law supports medtech, research and pharma organisations
We work with companies, research institutions and innovation-focused organisations to deliver immigration advice that supports long-term capability.
Our support includes:
- Advising on visa strategies for highly specialised roles
- Supporting global mobility for researchers and technical leaders
- Structuring pathways from temporary to permanent residence
- Managing compliance obligations without slowing innovation
- Reducing immigration risk around critical personnel
We understand the commercial and research pressures that define this sector.
Immigration planning that supports innovation
The strongest outcomes come when immigration is planned alongside research, funding and commercial timelines. This allows organisations to focus on development and delivery, not visa uncertainty.
That is where we add the most value.
Speak to an immigration lawyer who understands medtech, research and pharma
If your organisation relies on specialised global talent, Roam Migration Law can help you build an immigration strategy that supports innovation and growth.
Contact us to discuss your workforce needs and next steps.